Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer

Saved in:
Bibliographic Details
Published inAnnals of translational medicine Vol. 11; no. 5; p. 229
Main Authors Nakai, Hidekatsu, Matsumura, Noriomi
Format Journal Article
LanguageEnglish
Published China AME Publishing Company 15.03.2023
Subjects
bevacizumab
BOOST trial
Ovarian cancer
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ORCID: Hidekatsu Nakai, 0000-0002-9994-2131; Noriomi Matsumura, 0000-0002-4512-7975.
ISSN:2305-5839
2305-5839
DOI:10.21037/atm-22-6389